Liva Healthcare Acquires Discover Momenta (including Momenta Newcastle)
February 5, 2025
Liva Healthcare has acquired UK-based Discover Momenta, including its subsidiary Momenta Newcastle, for an undisclosed sum. The deal, enabled by a new investment led by Nupo / IBL Group alongside existing investors (MIG, Santos, Maj Invest and others), expands Liva’s evidence-based lifestyle-disease programmes and increases its reach within the NHS and other public-sector customers in the UK.
- Buyers
- Liva Healthcare, Nupo (IBL Group), MIG, Santos, Maj Invest, Other private investors
- Targets
- Discover Momenta, Momenta Newcastle
- Industry
- Healthcare Services
- Location
- England, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Civica Group Acquires Momentum Healthware
May 10, 2022
Software
UK-based Civica Group has acquired Canadian healthcare technology provider Momentum Healthware (which will operate as Civica Canada). The deal strengthens Civica's presence in North America and expands its health-and-care software capabilities—including EHR, assessment management and real-time location tracking—across senior care, long-term care and home care markets.
-
Mosaic Acquires Momentum
November 15, 2024
Healthcare Services
Mosaic, through its Living Innovations service, has acquired Momentum, a Maine behavioral health provider that delivers shared living and community-based services for people with intellectual and developmental disabilities. The deal brings Momentum into the Living Innovations/Mosaic network, expanding service reach across Maine, New Hampshire, Rhode Island and Connecticut and aiming to provide greater long-term stability and resources for Momentum's programs and workforce.
-
DiscernDx Acquires Luminist Labs
April 29, 2020
Biotechnology
DiscernDx, a Palo Alto precision medicine company, has acquired Luminist Labs, a privately-held diagnostic platform developer focused on early detection and diagnosis of liver disease. The acquisition will integrate Luminist's data and platform into DiscernDx's multi-omics system to accelerate development of non-invasive diagnostic and prognostic solutions for NASH and other chronic metabolic liver diseases. Terms were not disclosed.
-
Lupin Healthcare Acquires Renascience Pharma Limited (UK)
April 2, 2025
Pharmaceuticals
Lupin Healthcare (UK) Limited, a wholly owned subsidiary of Lupin Limited, has acquired UK-based Renascience Pharma Limited, the sole supplier of four specialty branded products in the UK. The acquisition (reported at approximately £12.3 million) expands Lupin's branded specialty portfolio in the UK and strengthens its supply offerings to the NHS across infectious disease, ENT and cardiology/renal indications.
-
IK Partners Acquires Medica Group
July 7, 2023
Healthcare Services
IK Partners, via newly incorporated Moonlight Bidco Limited, has completed its acquisition of Medica Group Plc, a market-leading teleradiology and imaging-services provider headquartered in Hastings, UK. The transaction (effective 6 July 2023) takes Medica private; IK says it will support Medica's growth by investing in people, technology and new capabilities, including through M&A.
-
MultiPlan Corporation Acquires Discovery Health Partners
January 21, 2021
Healthcare Services
MultiPlan Corporation agreed to acquire Discovery Health Partners for about $155 million plus transaction costs. The acquisition expands MultiPlan’s payment integrity capabilities by adding Discovery’s revenue integrity service line, deepening its penetration in the government market and extending its suite of analytics-driven cost-management solutions for health payors.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.